Results 91 to 100 of about 10,572,916 (223)

Demographic and viro-immunological characteristics of 154 HIV-1-infected patients, according to immunological response to combination antiretroviral therapy.

open access: yes, 2013
Data are reported as means (standard deviation), or numbers (percentages), as appropriate.FR  =  full responders; INR  =  immunological non responders; IVDU  =  intravenous drug users; MSM  =  men that make sex with men; HETERO  =  heterosexual; CDC ...
Giuliano Rizzardini (103636)   +10 more
core   +1 more source

A simple clinical score to identify likely hepatitis B vaccination non-responders - data from a retrospective single center study.

open access: yes, 2020
BACKGROUND About 10% of Hepatitis B vaccinated individuals mount no protective antibody levels against the hepatitis B surface antigen (HBs-Ag). Older age at primary immunization, obesity and smoking have previously been reported as risk factors ...
Berger CT, Meier MA
core   +1 more source

HIV-infected immunological non-responders have colon-restricted gut mucosal immune dysfunction

open access: yes, 2020
Abstract Background Human immunodeficiency virus (HIV)–infected immunological nonresponders (INRs) fail to reconstitute their CD4+ T-cell pool after initiation of antiretroviral therapy, and their prognosis is inferior to that of immunological responders (IRs).
Meyer-Myklestad, Malin Holm   +12 more
openaire   +2 more sources

Patient characteristics.

open access: yes, 2015
List of abbreviations: AIDS, acquired immunodeficiency syndrome; HAART, highly-active antiretroviral treatment; HBsAg, hepatitis B surface antigen; HCV-Ab, hepatitis C virus antibodies; HIV, human immunodeficiency virus; INR, immunological non-responders;
Massimo Di Pietro (237801)   +12 more
core   +1 more source

Artificial Intelligence–Based Online Symptom Assessment Tools for Systemic Lupus Erythematosus Diagnosis: Patient Perspectives

open access: yesArthritis Care &Research, EarlyView.
Objective The objective of this article is to identify perceptions of patients with systemic lupus erythematosus (SLE) regarding artificial intelligence (AI)–based online symptom assessment tools, and the potential of these tools to address diagnostic barriers.
Olivia A. Stein   +7 more
wiley   +1 more source

Clinical details of imatinib responders and non-responders.

open access: yes, 2015
Clinical details of imatinib responders and non-responders.
Shantashri Vaidya (687214)   +4 more
core   +1 more source

Enhanced Expression of Two ISGs as Potential Biomarkers of Prognosis in HIV-Infected Immunological Non-Responders

open access: yesZoonoses
Objective: No novel biomarkers are currently available for evaluating immune reconstitution among people living with HIV/AIDS (PLWH) receiving combined antiretroviral treatment (cART). The objective of this study was to analyze the expression patterns of interferon-stimulating genes (ISGs) in PLWH with the aim of identifying potential biomarkers for ...
Zhang, Xin   +5 more
openaire   +4 more sources

Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey

open access: yesArthritis Care &Research, EarlyView.
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa   +3 more
wiley   +1 more source

Differences in socio-demographic characteristics between responders and non-responders.

open access: yes, 2018
Differences in socio-demographic characteristics between responders and non-responders.
James M. Rhyne (5278958)   +5 more
core   +1 more source

Physical activity “responders” vs “non-responders” after exercise training with air or oxygen in people with COPD and exercise-induced desaturation

open access: yes, 2020
Aim: To evaluate changes in physical activity (PA) following exercise training on air or oxygen in people with COPD and EID. Methods: Secondary analysis of data from the "suppORT" trial was performed.
Zoe McKeough   +25 more
core   +1 more source

Home - About - Disclaimer - Privacy